Personalized medicine: Blood tests combined with genome sequencing yield breakthrough therapy

| June 4, 2012
play DNA
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.
Personalized genomic medicine has long been expected to blossom as sequencing of an individual’s human genome is nearing the $1,000 mark. In a remarkable new story, one professor, who sequenced his own genome, found that he was a high risk for Type 2 diabetes—then used blood tests to find out if he might develop the disease. Seven months into the experiment, he developed diabetes and began treatment, long before it might have been if the professor had relied on a conventional visits to the doctor.
Additional Resources:

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend